Independent research on India's industrial input dependence · Published weekly

Feedstock India

← Back to tracker

Rifampicin

PLI target segment: Segment II — fermentation-based niche KSMs/DIs/APIs
HS code(s): Not published
China share of India's imports: Not known
Trend vs. previous year: – Not known
On PLI critical bulk drug list: Yes
Approved project (applicant named): Macleods
Domestic capacity commissioned: Not known
End-use category: Antibiotic
Last updated: 24 Sept 2026

Sources